CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday - CACI International

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Keybanc raised Invitation Homes Inc. (NYSE:INVH) price target from $35 to $38. Keybanc analyst Austin Wurschmidt maintained an Overweight rating. Invitation Homes shares fell 0.3% to close at $33.98 on Thursday. See how other analysts view this stock.
Needham boosted the price target for The Simply Good Foods Company (NASDAQ:SMPL) from $42 to $45. Needham analyst Matt McGinley maintained a Buy rating. Simply Good Foods shares gained 7.8% to close at $42.69 on Thursday. See how other analysts view this stock.
Raymond James raised the price target for Tradeweb Markets Inc. (NASDAQ:TW) from $94 to $102. Raymond James analyst Patrick O'Shaughnessy maintained an Outperform rating. Tradeweb Markets shares gained 6.9% to close at $95.10 on Thursday. See how other analysts view this stock.
Stifel increased CACI International Inc (NYSE:CACI) price target from $365 to $380. Stifel analyst Bert Subin upgraded the stock from Hold to Buy. CACI International shares fell 0.4% to close at $314.31 on Thursday. See how other analysts view this stock.
Morgan Stanley boosted the price target for Cytokinetics, Incorporated (NASDAQ:CYTK) from $60 to $90. Morgan Stanley analyst Jeffrey Hung downgraded the stock from Overweight to Equal-Weight. Cytokinetics shares rose 1.9% to close at $88.24 on Thursday. See how other analysts view this stock.
Jefferies increased the price target for Okta, Inc. (NASDAQ:OKTA) from $85 to $95. Jefferies analyst Brent Thill downgraded the stock from Buy to Hold. Okta shares fell 0.6% to close at $83.37 on Thursday. See how other analysts view this stock.
HC Wainwright & Co. cut Viracta Therapeutics, Inc. (NASDAQ:VIRX) price target from $10 to $4. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating. Viracta Therapeutics shares gained 4.4% to close at $0.6054 on Thursday. See how other analysts view this stock.
Morgan Stanley cut CI&T Inc (NYSE:CINT) price target from $6 to $5.5. Morgan Stanley analyst Cesar Medina downgraded the stock from Overweight to Equal-Weight. > CI&T shares fell 0.4% to close at $5.06 on Thursday. See how other analysts view this stock.
Baird boosted Rexford Industrial Realty, Inc. (NYSE:REXR) price target from $53 to $61. Baird analyst David Rodgers downgraded the stock from Outperform to Neutral. Rexford Industrial Realty shares rose 0.1% to close at $55.21 on Thursday. See how other analysts view this stock.
Needham cut Mobileye Global Inc. (NASDAQ:MBLY) price target from $43 to $36. Needham analyst Quinn Bolton maintained a Buy rating. Mobileye Global shares fell 24.6% to close at $29.97 on Thursday. See how other analysts view this stock.